EVI
Jan 14, 20191 min
Updated: Jul 2, 2020
EVI-supported project publishes first clinical results for vaccine candidate to prevent pregnancy-associated malaria.
First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria.
For full article, please click the following link: